MDGL insider trading
NasdaqGS HealthcareMADRIGAL PHARMACEUTICALS, INC. — scored insider trade history from SEC Form 4 filings, parsed and contextualised by FilingIQ.
About MADRIGAL PHARMACEUTICALS, INC.
Madrigal Pharmaceuticals, Inc., a biopharmaceutical company, focuses on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH) in the United States. It offers Rezdiffra, a liver-directed thyroid hormone receptor beta agonist for treating MASH. The company is headquartered in West Conshohocken, Pennsylvania.
Company website: www.madrigalpharma.com
MDGL insider activity at a glance
FilingIQ has scored 936 insider transactions for MDGL since Jul 22, 2016. The most recent filing in our index is dated Mar 6, 2026.
Across the full history, 217 open-market purchases
and 496 open-market sales
were filed under transaction codes P and S respectively. Compensatory share awards
(code A) and option exercises (code M) are tracked separately and not counted here.
The average FilingIQ composite score on MDGL insider trades is 59.3/100, produced by FilingIQ's multi-factor Form 4 model. Model framework documented at methodology.
Latest MDGL Form 4 filings
Most recent disclosures. Sign up to filter by score, transaction code, or insider role.
Other Healthcare tickers with recent insider activity
Top insiders trading MDGL
13F funds holding MDGL
Frequently asked
- How many insider trades does FilingIQ track for MDGL?
- FilingIQ tracks 936 Form 4 insider transactions for MDGL (MADRIGAL PHARMACEUTICALS, INC.), covering filings from Jul 22, 2016 onwards. 29 of those were filed in the last 90 days.
- Are MDGL insiders net buyers or net sellers?
- Across the full Form 4 history for MDGL, 217 transactions (23%) were open-market purchases and 496 (53%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
- Where does MDGL insider data come from?
- Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.
- What sector is MDGL in?
- MADRIGAL PHARMACEUTICALS, INC. (MDGL) is classified in the Healthcare sector, specifically Biotechnology, with a current market capitalisation of $10.15B.
Methodology & sources
Every MDGL insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). The FilingIQ composite score is documented in full on the team page and algo disclosure. Not investment advice; see disclaimer.